FRANKFURT--The following is a summary of analysts' forecasts for
Novartis AG (NVS) second-quarter results, based on a poll of six
analysts conducted by Dow Jones Newswires (figures in million
dollars, EPS in dollar, DPS and target price in francs, according
to IFRS). Earnings figures are scheduled to be released July
17.
===
Net sales:
2nd Quarter -total -Pharma -Diovan -Gleevec -Lucentis
AVERAGE 14,764 8,191 789 1,137 600
Prev. Year 14,488 8,121 928 1,190 576
+/- in % +1.9 +0.9 -15 -4.5 +4.1
MEDIAN 14,797 8,204 780 1,152 599
Maximum 14,872 8,239 813 1,197 611
Minimum 14,622 8,117 761 1,047 588
Amount (a) 6 5 5 4 5
Deutsche Bank 14,872 8,239 810 1,197 588
Helvea 14,789 8,187 761 1,160 605
J.P. Morgan 14,808 8,208 779 -- 611
Morgan Stanley 14,687 -- -- -- --
Zuercher KB 14,622 8,117 780 1,047 599
Core Core Net
Operating Operating Net Net attrib.
2nd Quarter income income income income profit
AVERAGE 3,116 3,853 2,682 3,353 2,602
Prev. Year 2,970 3,755 2,548 3,227 2,516
+/- in % +4.9 +2.6 +5.2 +3.9 +3.4
MEDIAN 3,125 3,838 2,694 3,334 2,639
Maximum 3,385 3,998 2,882 3,473 2,665
Minimum 2,902 3,776 2,498 3,298 2,466
Amount (a) 5 6 5 5 4
Deutsche Bank 3,125 3,998 2,696 3,473 2,664
Helvea 2,902 3,834 2,498 3,318 2,466
J.P. Morgan 3,385 3,862 2,882 3,334 --
Morgan Stanley -- 3,776 -- -- --
Zuercher KB 3,019 3,809 2,638 3,298 2,614
Core
2nd Quarter EPS EPS
AVERAGE 1.09 1.36
Prev. Year 1.03 1.30
+/- in % +5.6 +4.5
MEDIAN 1.09 1.36
Maximum 1.17 1.42
Minimum 1.01 1.32
Amount (a) 5 6
Deutsche Bank 1.10 1.42
Helvea 1.01 1.35
J.P. Morgan 1.17 1.36
Morgan Stanley -- 1.34
Zuercher KB 1.07 1.32
Target price Rating DPS 2014
AVERAGE 84.17 positive 4 AVERAGE 2.55
Prev. Quarter 76.25 neutral 1 Prev. Year 2.45
+/- in % +10 negative 1 +/- in % +4.2
MEDIAN 81.50 MEDIAN 2.56
Maximum 92.00 Maximum 2.60
Minimum 79.00 Minimum 2.50
Amount 3 Amount 3
Bryan Garnier 81.50 Buy --
Deutsche Bank 79.00 Hold 2.60
Helvea 92.00 Buy 2.56
J.P. Morgan -- Overweight --
Morgan Stanley -- Underweight --
Zuercher KB -- Overweight 2.50
===
Year-earlier figures are as reported by the company.
(a) Including anonymous estimates from one more analyst.
DJG/voi
Subscribe to WSJ: http://online.wsj.com?mod=djnwires